| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 28 | 2022 | 146 | 7.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 32 | 2022 | 130 | 6.850 |
Why?
|
| Orthopedics | 18 | 2022 | 88 | 5.340 |
Why?
|
| Internship and Residency | 15 | 2022 | 596 | 3.930 |
Why?
|
| Ossification, Heterotopic | 16 | 2019 | 45 | 3.380 |
Why?
|
| Hip Prosthesis | 26 | 2015 | 85 | 2.720 |
Why?
|
| Blast Injuries | 5 | 2019 | 15 | 2.340 |
Why?
|
| Education, Medical, Graduate | 7 | 2022 | 214 | 2.290 |
Why?
|
| Personnel Staffing and Scheduling | 5 | 2020 | 64 | 1.780 |
Why?
|
| Postoperative Complications | 32 | 2021 | 1615 | 1.760 |
Why?
|
| Competency-Based Education | 4 | 2022 | 32 | 1.740 |
Why?
|
| Femur | 9 | 2020 | 113 | 1.730 |
Why?
|
| Osteoarthritis | 16 | 2016 | 73 | 1.610 |
Why?
|
| Amputation, Traumatic | 3 | 2019 | 11 | 1.580 |
Why?
|
| Thumb | 15 | 2005 | 27 | 1.440 |
Why?
|
| Anticoagulants | 13 | 2022 | 356 | 1.360 |
Why?
|
| Hip Joint | 8 | 2016 | 64 | 1.340 |
Why?
|
| Venous Thromboembolism | 4 | 2020 | 117 | 1.310 |
Why?
|
| Venous Thrombosis | 5 | 2010 | 125 | 1.300 |
Why?
|
| Workload | 4 | 2017 | 103 | 1.250 |
Why?
|
| Clinical Competence | 5 | 2017 | 657 | 1.150 |
Why?
|
| Pulmonary Embolism | 7 | 2022 | 253 | 1.150 |
Why?
|
| Knee Prosthesis | 13 | 2020 | 64 | 1.130 |
Why?
|
| Humans | 131 | 2022 | 68549 | 1.080 |
Why?
|
| Radiation Dosage | 2 | 2019 | 419 | 1.070 |
Why?
|
| Range of Motion, Articular | 5 | 2020 | 139 | 0.950 |
Why?
|
| Accreditation | 3 | 2020 | 72 | 0.930 |
Why?
|
| Acetabulum | 3 | 2012 | 20 | 0.930 |
Why?
|
| Aspirin | 5 | 2020 | 295 | 0.840 |
Why?
|
| Time Factors | 19 | 2020 | 4655 | 0.820 |
Why?
|
| Patient Readmission | 7 | 2019 | 267 | 0.810 |
Why?
|
| Femoral Fractures | 2 | 2018 | 45 | 0.810 |
Why?
|
| Fracture Healing | 2 | 2018 | 29 | 0.800 |
Why?
|
| Disease Models, Animal | 9 | 2019 | 2550 | 0.800 |
Why?
|
| Arthroplasty, Replacement | 3 | 2015 | 48 | 0.790 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2020 | 148 | 0.780 |
Why?
|
| Faculty, Medical | 2 | 2020 | 110 | 0.780 |
Why?
|
| Simulation Training | 1 | 2022 | 49 | 0.770 |
Why?
|
| Osteoarthritis, Hip | 4 | 2021 | 12 | 0.770 |
Why?
|
| Bone Cements | 2 | 2021 | 39 | 0.760 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 281 | 0.740 |
Why?
|
| Muscle, Skeletal | 4 | 2017 | 396 | 0.730 |
Why?
|
| Licensure, Medical | 1 | 2020 | 12 | 0.720 |
Why?
|
| Selection Bias | 1 | 2020 | 23 | 0.720 |
Why?
|
| Patient Safety | 2 | 2012 | 202 | 0.720 |
Why?
|
| Decision Making, Organizational | 2 | 2019 | 23 | 0.710 |
Why?
|
| Orthopedic Procedures | 3 | 2017 | 102 | 0.700 |
Why?
|
| Schools, Medical | 1 | 2021 | 157 | 0.690 |
Why?
|
| Necrosis | 2 | 2017 | 239 | 0.680 |
Why?
|
| Hindlimb | 2 | 2017 | 38 | 0.660 |
Why?
|
| Finger Joint | 7 | 2011 | 9 | 0.650 |
Why?
|
| Calcinosis | 2 | 2017 | 241 | 0.650 |
Why?
|
| Indomethacin | 1 | 2019 | 107 | 0.650 |
Why?
|
| Organizational Objectives | 1 | 2019 | 70 | 0.650 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 239 | 0.640 |
Why?
|
| Cadaver | 8 | 2020 | 136 | 0.640 |
Why?
|
| Blood Loss, Surgical | 3 | 2017 | 79 | 0.640 |
Why?
|
| Osteogenesis | 2 | 2018 | 152 | 0.640 |
Why?
|
| Thromboembolism | 5 | 2006 | 91 | 0.620 |
Why?
|
| Mentors | 2 | 2009 | 81 | 0.600 |
Why?
|
| Therapeutic Irrigation | 1 | 2017 | 63 | 0.600 |
Why?
|
| Radiography | 17 | 2015 | 572 | 0.600 |
Why?
|
| Male | 54 | 2020 | 37283 | 0.590 |
Why?
|
| Tranexamic Acid | 1 | 2017 | 37 | 0.560 |
Why?
|
| Antifibrinolytic Agents | 1 | 2017 | 52 | 0.560 |
Why?
|
| Biomedical Research | 2 | 2012 | 310 | 0.540 |
Why?
|
| Ligaments, Articular | 8 | 2005 | 21 | 0.530 |
Why?
|
| United States | 17 | 2022 | 7338 | 0.530 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2019 | 2083 | 0.530 |
Why?
|
| Fracture Fixation | 2 | 2011 | 32 | 0.520 |
Why?
|
| Cartilage, Articular | 6 | 1995 | 38 | 0.510 |
Why?
|
| Warfarin | 10 | 2011 | 93 | 0.510 |
Why?
|
| Wrist Joint | 5 | 1996 | 15 | 0.510 |
Why?
|
| Tendons | 5 | 2011 | 45 | 0.500 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 445 | 0.500 |
Why?
|
| Forearm | 1 | 2014 | 25 | 0.490 |
Why?
|
| Compartment Syndromes | 1 | 2014 | 13 | 0.480 |
Why?
|
| Bandages | 2 | 2014 | 33 | 0.480 |
Why?
|
| Prosthesis Design | 7 | 2020 | 301 | 0.480 |
Why?
|
| Fractures, Bone | 7 | 2018 | 132 | 0.480 |
Why?
|
| Biomechanical Phenomena | 7 | 2020 | 368 | 0.470 |
Why?
|
| Physicians | 2 | 2009 | 324 | 0.460 |
Why?
|
| Intervertebral Disc | 4 | 2017 | 51 | 0.450 |
Why?
|
| Patient Reported Outcome Measures | 4 | 2022 | 114 | 0.440 |
Why?
|
| Knee Joint | 6 | 2021 | 115 | 0.440 |
Why?
|
| Ilium | 1 | 2012 | 16 | 0.430 |
Why?
|
| Work Schedule Tolerance | 1 | 2012 | 18 | 0.430 |
Why?
|
| Middle Aged | 37 | 2020 | 21119 | 0.420 |
Why?
|
| Reoperation | 10 | 2020 | 467 | 0.420 |
Why?
|
| Metacarpus | 4 | 1997 | 5 | 0.410 |
Why?
|
| Aged | 30 | 2019 | 14842 | 0.410 |
Why?
|
| Medical Errors | 1 | 2012 | 80 | 0.400 |
Why?
|
| Arthroplasty | 7 | 2020 | 24 | 0.400 |
Why?
|
| Models, Biological | 2 | 2009 | 981 | 0.400 |
Why?
|
| Tenodesis | 1 | 2011 | 2 | 0.390 |
Why?
|
| Thrombophlebitis | 11 | 1997 | 47 | 0.390 |
Why?
|
| Frozen Sections | 1 | 2011 | 14 | 0.390 |
Why?
|
| Suture Techniques | 1 | 2011 | 75 | 0.380 |
Why?
|
| Burnout, Professional | 2 | 2009 | 64 | 0.380 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2009 | 54 | 0.380 |
Why?
|
| Practice Guidelines as Topic | 5 | 2011 | 772 | 0.370 |
Why?
|
| Equipment and Supplies | 1 | 2010 | 18 | 0.360 |
Why?
|
| Animals | 16 | 2019 | 20880 | 0.360 |
Why?
|
| Bone Screws | 1 | 2011 | 90 | 0.360 |
Why?
|
| Tibia | 2 | 2021 | 93 | 0.360 |
Why?
|
| Industry | 1 | 2010 | 28 | 0.350 |
Why?
|
| Female | 45 | 2020 | 38021 | 0.350 |
Why?
|
| Joint Diseases | 1 | 2009 | 37 | 0.350 |
Why?
|
| Conflict of Interest | 1 | 2010 | 48 | 0.340 |
Why?
|
| Phlebography | 5 | 2005 | 31 | 0.340 |
Why?
|
| Carpal Bones | 4 | 1997 | 7 | 0.340 |
Why?
|
| Trust | 1 | 2010 | 75 | 0.340 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 168 | 0.340 |
Why?
|
| Obstetrics | 1 | 2009 | 44 | 0.330 |
Why?
|
| Gynecology | 1 | 2009 | 46 | 0.330 |
Why?
|
| Job Satisfaction | 1 | 2009 | 62 | 0.320 |
Why?
|
| Office Visits | 1 | 2009 | 83 | 0.320 |
Why?
|
| Career Choice | 3 | 2017 | 98 | 0.300 |
Why?
|
| Ulnar Nerve Compression Syndromes | 1 | 2007 | 1 | 0.300 |
Why?
|
| Muscles | 3 | 2019 | 158 | 0.300 |
Why?
|
| Preoperative Care | 4 | 2020 | 275 | 0.290 |
Why?
|
| Bone Remodeling | 2 | 2009 | 45 | 0.280 |
Why?
|
| Adult | 25 | 2022 | 21379 | 0.280 |
Why?
|
| Hip Fractures | 1 | 2006 | 26 | 0.270 |
Why?
|
| Registries | 1 | 2009 | 730 | 0.270 |
Why?
|
| Arthritis | 3 | 2000 | 53 | 0.270 |
Why?
|
| Rotation | 2 | 2020 | 58 | 0.270 |
Why?
|
| Intergenerational Relations | 1 | 2005 | 8 | 0.270 |
Why?
|
| Osteoporosis | 1 | 2006 | 88 | 0.260 |
Why?
|
| Rabbits | 4 | 2013 | 509 | 0.260 |
Why?
|
| Aged, 80 and over | 12 | 2011 | 4843 | 0.250 |
Why?
|
| Postoperative Care | 6 | 2009 | 163 | 0.250 |
Why?
|
| Retrospective Studies | 13 | 2021 | 7268 | 0.250 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 188 | 0.250 |
Why?
|
| Thrombosis | 2 | 1998 | 218 | 0.250 |
Why?
|
| Radiotherapy | 1 | 2005 | 86 | 0.250 |
Why?
|
| Fibrinolytic Agents | 1 | 2008 | 377 | 0.240 |
Why?
|
| Patella | 2 | 2009 | 14 | 0.240 |
Why?
|
| Prosthesis-Related Infections | 3 | 2009 | 70 | 0.240 |
Why?
|
| Referral and Consultation | 1 | 2006 | 383 | 0.230 |
Why?
|
| Postoperative Hemorrhage | 2 | 2017 | 69 | 0.230 |
Why?
|
| Prospective Studies | 14 | 2019 | 3703 | 0.230 |
Why?
|
| Osteoarthritis, Knee | 2 | 2021 | 26 | 0.230 |
Why?
|
| Leadership | 2 | 2019 | 136 | 0.230 |
Why?
|
| Stem Cells | 1 | 2005 | 248 | 0.220 |
Why?
|
| Osteoblasts | 2 | 2018 | 99 | 0.210 |
Why?
|
| Propensity Score | 1 | 2022 | 116 | 0.210 |
Why?
|
| Bone Resorption | 3 | 2005 | 64 | 0.210 |
Why?
|
| Tuberculosis, Osteoarticular | 1 | 2002 | 1 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 186 | 0.210 |
Why?
|
| X-Ray Microtomography | 2 | 2019 | 50 | 0.210 |
Why?
|
| Heparin, Low-Molecular-Weight | 4 | 2010 | 41 | 0.200 |
Why?
|
| Arthritis, Infectious | 1 | 2002 | 14 | 0.200 |
Why?
|
| Stress, Mechanical | 4 | 2016 | 208 | 0.200 |
Why?
|
| Health Facility Merger | 1 | 2001 | 3 | 0.200 |
Why?
|
| Joint Dislocations | 2 | 1993 | 40 | 0.200 |
Why?
|
| Prosthesis Failure | 6 | 2016 | 130 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2022 | 929 | 0.190 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 1851 | 0.190 |
Why?
|
| Torque | 1 | 2020 | 34 | 0.190 |
Why?
|
| Fingers | 3 | 1997 | 39 | 0.190 |
Why?
|
| Bone Density | 4 | 2009 | 159 | 0.180 |
Why?
|
| Polyethylene | 1 | 2020 | 31 | 0.180 |
Why?
|
| Hostility | 1 | 2020 | 19 | 0.180 |
Why?
|
| Wound Healing | 2 | 2019 | 260 | 0.180 |
Why?
|
| Training Support | 1 | 2020 | 17 | 0.180 |
Why?
|
| Sexism | 1 | 2020 | 11 | 0.180 |
Why?
|
| Chromium Alloys | 3 | 1995 | 16 | 0.180 |
Why?
|
| Radiotherapy Dosage | 7 | 2005 | 125 | 0.180 |
Why?
|
| Prejudice | 1 | 2020 | 37 | 0.180 |
Why?
|
| Electromyography | 3 | 2007 | 184 | 0.180 |
Why?
|
| Hip | 3 | 1994 | 19 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 3 | 2017 | 503 | 0.170 |
Why?
|
| Aggression | 1 | 2020 | 98 | 0.170 |
Why?
|
| Certification | 1 | 2020 | 66 | 0.170 |
Why?
|
| Sexual and Gender Minorities | 1 | 2020 | 37 | 0.170 |
Why?
|
| Cost Savings | 2 | 2017 | 110 | 0.170 |
Why?
|
| Risk Factors | 11 | 2019 | 5720 | 0.170 |
Why?
|
| Metacarpophalangeal Joint | 3 | 1995 | 8 | 0.170 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 95 | 0.170 |
Why?
|
| Blood Transfusion | 2 | 2017 | 205 | 0.170 |
Why?
|
| Rats | 3 | 2019 | 5300 | 0.160 |
Why?
|
| Osteocalcin | 1 | 2018 | 37 | 0.160 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 172 | 0.160 |
Why?
|
| Bone Nails | 1 | 2018 | 32 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 1998 | 25 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2020 | 1341 | 0.160 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 75 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 848 | 0.160 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2018 | 33 | 0.160 |
Why?
|
| Bone Plates | 1 | 2018 | 49 | 0.160 |
Why?
|
| Combined Modality Therapy | 3 | 2018 | 951 | 0.160 |
Why?
|
| Follow-Up Studies | 9 | 2007 | 3256 | 0.160 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 1998 | 12 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2011 | 1465 | 0.150 |
Why?
|
| Dissection | 1 | 1998 | 29 | 0.150 |
Why?
|
| Hyaline Cartilage | 1 | 2017 | 4 | 0.150 |
Why?
|
| Health Care Costs | 2 | 2018 | 346 | 0.150 |
Why?
|
| Decision Making | 2 | 2012 | 410 | 0.150 |
Why?
|
| Societies, Medical | 3 | 2011 | 403 | 0.150 |
Why?
|
| Electric Conductivity | 1 | 2017 | 87 | 0.150 |
Why?
|
| Family Practice | 1 | 2020 | 312 | 0.150 |
Why?
|
| Arthritis, Juvenile | 1 | 1997 | 70 | 0.150 |
Why?
|
| Health Personnel | 1 | 2020 | 286 | 0.140 |
Why?
|
| Reference Standards | 1 | 2017 | 115 | 0.140 |
Why?
|
| Urinary Catheterization | 1 | 1996 | 27 | 0.140 |
Why?
|
| Pressure | 2 | 2014 | 252 | 0.140 |
Why?
|
| Pediatrics | 1 | 2020 | 341 | 0.140 |
Why?
|
| Titanium | 2 | 1995 | 118 | 0.140 |
Why?
|
| Cartilage | 1 | 2016 | 51 | 0.140 |
Why?
|
| Osseointegration | 2 | 2009 | 19 | 0.140 |
Why?
|
| Awards and Prizes | 2 | 2006 | 27 | 0.140 |
Why?
|
| Finite Element Analysis | 2 | 2009 | 55 | 0.130 |
Why?
|
| Anesthesia, Epidural | 2 | 1994 | 11 | 0.130 |
Why?
|
| Medical Overuse | 1 | 2016 | 28 | 0.130 |
Why?
|
| Fibrosis | 2 | 2019 | 371 | 0.130 |
Why?
|
| Data Collection | 2 | 2009 | 420 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2016 | 86 | 0.130 |
Why?
|
| Osteotomy | 1 | 1996 | 46 | 0.130 |
Why?
|
| United Kingdom | 1 | 2015 | 152 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 1997 | 163 | 0.130 |
Why?
|
| Cross-Cultural Comparison | 1 | 1995 | 68 | 0.130 |
Why?
|
| Medicare | 4 | 2019 | 316 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2016 | 141 | 0.130 |
Why?
|
| Canada | 1 | 2015 | 266 | 0.120 |
Why?
|
| Compliance | 1 | 2014 | 26 | 0.120 |
Why?
|
| Synovial Membrane | 1 | 1994 | 23 | 0.120 |
Why?
|
| Glucose | 1 | 2016 | 307 | 0.120 |
Why?
|
| Foreign Bodies | 1 | 1994 | 58 | 0.120 |
Why?
|
| Models, Animal | 2 | 2005 | 252 | 0.120 |
Why?
|
| Arm | 1 | 1993 | 59 | 0.110 |
Why?
|
| Prevalence | 3 | 2009 | 1609 | 0.110 |
Why?
|
| Antithrombin III | 5 | 1991 | 23 | 0.110 |
Why?
|
| Buttocks | 1 | 2013 | 16 | 0.110 |
Why?
|
| Chondrocytes | 1 | 2013 | 27 | 0.110 |
Why?
|
| Cognition | 1 | 2017 | 512 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2017 | 413 | 0.110 |
Why?
|
| Sciatic Nerve | 1 | 1992 | 26 | 0.110 |
Why?
|
| Nerve Compression Syndromes | 1 | 1992 | 16 | 0.110 |
Why?
|
| Equipment Design | 1 | 2014 | 500 | 0.110 |
Why?
|
| Hematoma | 1 | 2013 | 47 | 0.110 |
Why?
|
| Aneurysm | 1 | 1992 | 53 | 0.110 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2007 | 13 | 0.100 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 1753 | 0.100 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1992 | 79 | 0.100 |
Why?
|
| Extremities | 1 | 2011 | 49 | 0.100 |
Why?
|
| Warfare | 1 | 2012 | 58 | 0.100 |
Why?
|
| Polysaccharides | 2 | 2010 | 176 | 0.100 |
Why?
|
| Carpal Joints | 1 | 2011 | 1 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 2798 | 0.100 |
Why?
|
| Military Medicine | 1 | 2012 | 53 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2019 | 7028 | 0.100 |
Why?
|
| Educational Status | 1 | 2012 | 273 | 0.100 |
Why?
|
| Tensile Strength | 1 | 2011 | 90 | 0.100 |
Why?
|
| Intraoperative Period | 1 | 2011 | 62 | 0.100 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2010 | 373 | 0.090 |
Why?
|
| Fatigue | 1 | 2012 | 132 | 0.090 |
Why?
|
| Glycosaminoglycans | 3 | 2016 | 88 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2020 | 1032 | 0.090 |
Why?
|
| Intermittent Pneumatic Compression Devices | 1 | 2010 | 6 | 0.090 |
Why?
|
| Young Adult | 1 | 2022 | 5710 | 0.090 |
Why?
|
| Chemoprevention | 1 | 2010 | 26 | 0.090 |
Why?
|
| Choristoma | 1 | 1990 | 20 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1990 | 28 | 0.090 |
Why?
|
| Intellectual Property | 1 | 2010 | 2 | 0.090 |
Why?
|
| Device Approval | 1 | 2010 | 6 | 0.090 |
Why?
|
| Gift Giving | 1 | 2010 | 10 | 0.090 |
Why?
|
| Licensure | 1 | 2010 | 18 | 0.090 |
Why?
|
| Government Regulation | 1 | 2010 | 46 | 0.090 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 49 | 0.090 |
Why?
|
| Heparin | 5 | 1991 | 205 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 122 | 0.090 |
Why?
|
| Students, Medical | 1 | 2012 | 210 | 0.090 |
Why?
|
| Disclosure | 1 | 2010 | 45 | 0.090 |
Why?
|
| Bone and Bones | 1 | 1990 | 145 | 0.090 |
Why?
|
| Diffusion of Innovation | 1 | 2010 | 102 | 0.080 |
Why?
|
| Delaware | 1 | 2009 | 4 | 0.080 |
Why?
|
| New Jersey | 1 | 2009 | 8 | 0.080 |
Why?
|
| Biomedical Engineering | 1 | 2009 | 20 | 0.080 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.080 |
Why?
|
| Pennsylvania | 1 | 2009 | 46 | 0.080 |
Why?
|
| Atrophy | 1 | 2009 | 112 | 0.080 |
Why?
|
| Curriculum | 2 | 2017 | 575 | 0.080 |
Why?
|
| Materials Testing | 1 | 2009 | 263 | 0.080 |
Why?
|
| Hand-Arm Vibration Syndrome | 1 | 2007 | 1 | 0.080 |
Why?
|
| Ulnar Artery | 1 | 2007 | 2 | 0.080 |
Why?
|
| Ulnar Nerve | 1 | 2007 | 7 | 0.080 |
Why?
|
| Electrodiagnosis | 1 | 2007 | 12 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2006 | 1549 | 0.080 |
Why?
|
| Hand Injuries | 1 | 2007 | 9 | 0.080 |
Why?
|
| Wrist Injuries | 1 | 2007 | 9 | 0.080 |
Why?
|
| Neurologic Examination | 1 | 2007 | 107 | 0.070 |
Why?
|
| Decompression, Surgical | 1 | 2007 | 55 | 0.070 |
Why?
|
| Incidence | 4 | 2016 | 1582 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2011 | 503 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 247 | 0.070 |
Why?
|
| Hemorrhage | 3 | 2005 | 328 | 0.070 |
Why?
|
| Nail Diseases | 1 | 1986 | 13 | 0.070 |
Why?
|
| Keratoacanthoma | 1 | 1986 | 8 | 0.070 |
Why?
|
| Tendon Transfer | 1 | 1986 | 7 | 0.070 |
Why?
|
| Professional Practice | 1 | 2006 | 47 | 0.070 |
Why?
|
| Diphosphonates | 1 | 2006 | 39 | 0.070 |
Why?
|
| Psychometrics | 1 | 2009 | 514 | 0.070 |
Why?
|
| Professional Role | 1 | 2006 | 80 | 0.070 |
Why?
|
| Joint Prosthesis | 1 | 1986 | 48 | 0.070 |
Why?
|
| Leg | 2 | 1999 | 191 | 0.070 |
Why?
|
| Hospitalization | 2 | 2013 | 977 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 447 | 0.060 |
Why?
|
| Organizational Culture | 1 | 2005 | 59 | 0.060 |
Why?
|
| North America | 1 | 2005 | 111 | 0.060 |
Why?
|
| Tourniquets | 2 | 2012 | 18 | 0.060 |
Why?
|
| Postoperative Period | 2 | 1996 | 238 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2005 | 126 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1986 | 155 | 0.060 |
Why?
|
| Water | 2 | 2016 | 228 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2006 | 502 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 1998 | 1040 | 0.060 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.060 |
Why?
|
| Dextrans | 4 | 1990 | 33 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 1999 | 2077 | 0.060 |
Why?
|
| Sex Factors | 2 | 2020 | 1265 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 370 | 0.050 |
Why?
|
| Prognosis | 1 | 2008 | 2093 | 0.050 |
Why?
|
| Embolism, Fat | 1 | 1982 | 13 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 1983 | 112 | 0.050 |
Why?
|
| Pain | 2 | 1986 | 472 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2005 | 597 | 0.050 |
Why?
|
| Round Ligament of Uterus | 1 | 1981 | 1 | 0.050 |
Why?
|
| Financial Audit | 1 | 2001 | 3 | 0.050 |
Why?
|
| Adnexa Uteri | 1 | 1981 | 2 | 0.050 |
Why?
|
| Prothrombin Time | 2 | 2009 | 24 | 0.050 |
Why?
|
| Genital Neoplasms, Female | 1 | 1981 | 37 | 0.050 |
Why?
|
| Endometriosis | 1 | 1981 | 56 | 0.050 |
Why?
|
| Intraoperative Complications | 2 | 2000 | 129 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2001 | 61 | 0.050 |
Why?
|
| Arthralgia | 1 | 2021 | 30 | 0.050 |
Why?
|
| Weight-Bearing | 2 | 2005 | 53 | 0.050 |
Why?
|
| Joint Deformities, Acquired | 1 | 2000 | 5 | 0.050 |
Why?
|
| Splints | 1 | 2000 | 10 | 0.050 |
Why?
|
| Minimal Clinically Important Difference | 1 | 2019 | 8 | 0.040 |
Why?
|
| Bone Development | 1 | 2019 | 37 | 0.040 |
Why?
|
| Random Allocation | 2 | 1998 | 442 | 0.040 |
Why?
|
| Benzylamines | 1 | 2018 | 28 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 1999 | 57 | 0.040 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 24 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1998 | 84 | 0.040 |
Why?
|
| Pain Measurement | 1 | 1999 | 328 | 0.040 |
Why?
|
| Silicones | 2 | 1990 | 32 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2013 | 2356 | 0.040 |
Why?
|
| Fracture Fixation, Internal | 2 | 1989 | 68 | 0.040 |
Why?
|
| Reimbursement Mechanisms | 1 | 2018 | 37 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 1998 | 249 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2018 | 168 | 0.040 |
Why?
|
| Dalteparin | 1 | 1997 | 1 | 0.040 |
Why?
|
| Microcirculation | 1 | 1998 | 77 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 20 | 0.040 |
Why?
|
| Perioperative Care | 1 | 1998 | 100 | 0.040 |
Why?
|
| Observer Variation | 1 | 1998 | 330 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 1998 | 168 | 0.040 |
Why?
|
| Counseling | 1 | 2020 | 279 | 0.040 |
Why?
|
| Premedication | 1 | 1997 | 49 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2021 | 866 | 0.040 |
Why?
|
| Arteries | 1 | 1998 | 108 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 498 | 0.040 |
Why?
|
| Urinary Retention | 1 | 1996 | 20 | 0.040 |
Why?
|
| Catheters, Indwelling | 1 | 1996 | 72 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 1998 | 221 | 0.030 |
Why?
|
| Societies | 1 | 2016 | 15 | 0.030 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2016 | 20 | 0.030 |
Why?
|
| Diffusion | 1 | 2016 | 90 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1996 | 193 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 1996 | 71 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 780 | 0.030 |
Why?
|
| Episode of Care | 1 | 2015 | 12 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 765 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1033 | 0.030 |
Why?
|
| Singapore | 1 | 1995 | 7 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2016 | 49 | 0.030 |
Why?
|
| Hong Kong | 1 | 1995 | 11 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2015 | 25 | 0.030 |
Why?
|
| Femoral Neck Fractures | 1 | 1995 | 7 | 0.030 |
Why?
|
| Viscosity | 1 | 2015 | 72 | 0.030 |
Why?
|
| Japan | 1 | 1995 | 68 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 131 | 0.030 |
Why?
|
| Preventive Health Services | 1 | 2016 | 86 | 0.030 |
Why?
|
| Corrosion | 1 | 1995 | 61 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 211 | 0.030 |
Why?
|
| Elbow | 1 | 1994 | 6 | 0.030 |
Why?
|
| Elasticity | 1 | 1995 | 103 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 1995 | 83 | 0.030 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1994 | 29 | 0.030 |
Why?
|
| Knee | 1 | 1994 | 17 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 1996 | 233 | 0.030 |
Why?
|
| Synostosis | 1 | 1994 | 1 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1994 | 40 | 0.030 |
Why?
|
| Ulna Fractures | 1 | 1994 | 8 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 475 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 1995 | 306 | 0.030 |
Why?
|
| Joint Instability | 1 | 1995 | 87 | 0.030 |
Why?
|
| Radius Fractures | 1 | 1994 | 17 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 1994 | 33 | 0.030 |
Why?
|
| Methods | 1 | 1993 | 156 | 0.030 |
Why?
|
| Prothrombin | 1 | 1993 | 12 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1994 | 236 | 0.030 |
Why?
|
| Antigens | 1 | 1993 | 90 | 0.030 |
Why?
|
| Pronation | 1 | 1993 | 2 | 0.030 |
Why?
|
| Biopsy | 1 | 1995 | 539 | 0.030 |
Why?
|
| Cartilage Diseases | 1 | 1993 | 10 | 0.030 |
Why?
|
| Inflammation | 1 | 2019 | 1030 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 621 | 0.030 |
Why?
|
| Gravity Suits | 1 | 1992 | 1 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 1993 | 210 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 636 | 0.030 |
Why?
|
| Stockings, Compression | 1 | 2011 | 9 | 0.030 |
Why?
|
| Smoking | 1 | 2020 | 1449 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2012 | 85 | 0.020 |
Why?
|
| Income | 1 | 2012 | 165 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2011 | 107 | 0.020 |
Why?
|
| Physical Examination | 1 | 1992 | 152 | 0.020 |
Why?
|
| Research | 1 | 2012 | 214 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 546 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1992 | 319 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1997 | 3187 | 0.020 |
Why?
|
| Life Style | 1 | 2012 | 338 | 0.020 |
Why?
|
| Arthrodesis | 1 | 1990 | 21 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 285 | 0.020 |
Why?
|
| Osteolysis | 1 | 2009 | 15 | 0.020 |
Why?
|
| Leg Length Inequality | 1 | 2009 | 15 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2009 | 24 | 0.020 |
Why?
|
| Military Personnel | 1 | 2012 | 221 | 0.020 |
Why?
|
| Child | 2 | 1997 | 6401 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1990 | 159 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2009 | 91 | 0.020 |
Why?
|
| Immobilization | 1 | 1988 | 26 | 0.020 |
Why?
|
| Inpatients | 1 | 2009 | 208 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 1860 | 0.020 |
Why?
|
| Curettage | 1 | 1986 | 7 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2009 | 294 | 0.020 |
Why?
|
| Acute Disease | 1 | 1988 | 658 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 438 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 2265 | 0.020 |
Why?
|
| Osteoprotegerin | 1 | 2005 | 11 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 32 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 17 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2005 | 26 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 66 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2005 | 73 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2005 | 110 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2005 | 238 | 0.010 |
Why?
|
| Drug Therapy, Combination | 3 | 1990 | 648 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 1195 | 0.010 |
Why?
|
| Spine | 1 | 1983 | 46 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 2004 | 0.010 |
Why?
|
| Opsonin Proteins | 1 | 1982 | 4 | 0.010 |
Why?
|
| Mononuclear Phagocyte System | 1 | 1982 | 8 | 0.010 |
Why?
|
| Lipoproteins, VLDL | 1 | 1982 | 32 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1982 | 48 | 0.010 |
Why?
|
| Spinal Fusion | 1 | 1983 | 90 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1982 | 45 | 0.010 |
Why?
|
| Phagocytosis | 1 | 1982 | 65 | 0.010 |
Why?
|
| Triglycerides | 1 | 1982 | 184 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1982 | 186 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1851 | 0.010 |
Why?
|
| Veins | 1 | 2000 | 68 | 0.010 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1998 | 17 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1998 | 53 | 0.010 |
Why?
|
| Serum Amyloid A Protein | 1 | 1998 | 33 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1982 | 334 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1998 | 42 | 0.010 |
Why?
|
| Th2 Cells | 1 | 1998 | 48 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1998 | 69 | 0.010 |
Why?
|
| Anesthesia | 1 | 2000 | 120 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1998 | 133 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 1998 | 144 | 0.010 |
Why?
|
| Lung | 1 | 1982 | 849 | 0.010 |
Why?
|
| Survival Rate | 1 | 2000 | 1055 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1996 | 567 | 0.010 |
Why?
|
| Cytokines | 1 | 1998 | 866 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1993 | 411 | 0.010 |
Why?
|
| New York | 1 | 1992 | 223 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1992 | 172 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1992 | 219 | 0.010 |
Why?
|
| Hematocrit | 1 | 1990 | 70 | 0.010 |
Why?
|
| Adolescent | 1 | 1983 | 8904 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1989 | 47 | 0.010 |
Why?
|
| Mass Screening | 1 | 1992 | 838 | 0.000 |
Why?
|